Glp-1 Analogues Market Size, Share, By Product (Ozempic, Trulicity, Mounjaro, Xultophy, Victoza, Saxenda, and Others), By Drug Class (Semaglutide, Dulaglutide, Liraglutide, and Exenatide), By Route of Administration (Parenteral, and Oral), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and By Region - Trends, Analysis and Forecast till 2034

Product Development:

• Besides that, product development can further produce huge growth opportunities for companies operating in GLP-1 analogues. The convenience in dosage forms will turn out to be a key to better compliance and access for patients. Combining GLP-1 analogues with other anti-diabetic or weight loss drugs can develop combination therapies with higher therapeutic benefits. In addition, increasing its adoption among patients by reducing the injection frequency can be done by developing long-acting formulations, which prolong the action through a once-a-week or once-a-month dos.